Skip to content

Notes Issued1 at other companies

Repligen logo
RepligenRGEN
$0
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0
ATI
Archimedes Tech SPAC Partners II Co. Ordinary SharesATII
$0-100%
Equitable Holdings logo
Equitable HoldingsEQH
$0-100%
Huron Consulting Group logo
Huron Consulting GroupHURN
$0-100%
Beyond Meat logo
Beyond MeatBYND
$83.54M

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:NotesIssued1.

The official record: Pacific Biosciences of California’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's notes issued1.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's notes issued1?
Pacific Biosciences of California (PACB) reported notes issued1 of $0 in Q4 2025.
What does notes issued1 mean?
Represents the principal amount of debt securities issued by the company to raise capital. This metric indicates the company's reliance on debt financing to fund operations, research, or strategic initiatives.